Literature DB >> 15628874

Is the prion domain of soluble Ure2p unstructured?

Michael M Pierce1, Ulrich Baxa, Alasdair C Steven, Ad Bax, Reed B Wickner.   

Abstract

The [URE3] prion is a self-propagating amyloid form of the Ure2 protein of Saccharomyces cerevisiae. Deletions in the C-terminal nitrogen regulation domain of Ure2p increase the frequency with which the N-terminal prion domain polymerizes into the prion form, suggesting that the C-terminus stabilizes the prion domain or that the structured C-terminal region sterically impairs amyloid formation. We find by in vivo two-hybrid analysis no evidence of interaction of prion domain and C-terminal domain. Furthermore, surface plasmon resonance spectrometry shows no evidence of interaction of prion domain and C-terminal domain, and cleavage at a specific site between the domains frees the two fragments. Our NMR analysis indicates that most residues of the prion domain are in fact disordered in the soluble form of Ure2p. Deleting the tether holding the C-terminal structured region to the amyloid core does not impair prion formation, arguing against steric impairment of amyloid formation. These results suggest that the N-terminal prion domain is unstructured in the soluble protein and does not have a specific interaction with the C-terminus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15628874     DOI: 10.1021/bi047964d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

Review 1.  Prions: En route from structural models to structures.

Authors:  Anja Böckmann; Beat H Meier
Journal:  Prion       Date:  2010-04-05       Impact factor: 3.931

Review 2.  Prion amyloid structure explains templating: how proteins can be genes.

Authors:  Reed B Wickner; Frank Shewmaker; Herman Edskes; Dmitry Kryndushkin; Julie Nemecek; Ryan McGlinchey; David Bateman; Chia-Lin Winchester
Journal:  FEMS Yeast Res       Date:  2010-12       Impact factor: 2.796

3.  The core of Ure2p prion fibrils is formed by the N-terminal segment in a parallel cross-β structure: evidence from solid-state NMR.

Authors:  Dmitry S Kryndushkin; Reed B Wickner; Robert Tycko
Journal:  J Mol Biol       Date:  2011-04-08       Impact factor: 5.469

Review 4.  Prions of fungi: inherited structures and biological roles.

Authors:  Reed B Wickner; Herman K Edskes; Frank Shewmaker; Toru Nakayashiki
Journal:  Nat Rev Microbiol       Date:  2007-08       Impact factor: 60.633

Review 5.  Yeast prions and human prion-like proteins: sequence features and prediction methods.

Authors:  Sean M Cascarina; Eric D Ross
Journal:  Cell Mol Life Sci       Date:  2014-01-04       Impact factor: 9.261

Review 6.  Protein rescue from aggregates by powerful molecular chaperone machines.

Authors:  Shannon M Doyle; Olivier Genest; Sue Wickner
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10       Impact factor: 94.444

Review 7.  Protein inheritance (prions) based on parallel in-register beta-sheet amyloid structures.

Authors:  Reed B Wickner; Frank Shewmaker; Dmitry Kryndushkin; Herman K Edskes
Journal:  Bioessays       Date:  2008-10       Impact factor: 4.345

8.  The talin rod IBS2 alpha-helix interacts with the beta3 integrin cytoplasmic tail membrane-proximal helix by establishing charge complementary salt bridges.

Authors:  Sophie Rodius; Olivier Chaloin; Michèle Moes; Elisabeth Schaffner-Reckinger; Isabelle Landrieu; Guy Lippens; Minghui Lin; Ji Zhang; Nelly Kieffer
Journal:  J Biol Chem       Date:  2008-06-23       Impact factor: 5.157

9.  Extensive de novo solid-state NMR assignments of the 33 kDa C-terminal domain of the Ure2 prion.

Authors:  Birgit Habenstein; Christian Wasmer; Luc Bousset; Yannick Sourigues; Anne Schütz; Antoine Loquet; Beat H Meier; Ronald Melki; Anja Böckmann
Journal:  J Biomol NMR       Date:  2011-07-31       Impact factor: 2.835

Review 10.  Viruses and prions of Saccharomyces cerevisiae.

Authors:  Reed B Wickner; Tsutomu Fujimura; Rosa Esteban
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.